Efficacy of DB289 in Thai patients with plasmodium vivax or acute, uncomplicated Plasmodium falaparum infections

Journal of Infectious Diseases

Volumn 192, Issue 2, 2005, Pages 319-322

  Yeramian, Patrick ^a   Meshnick, Steven R ^b   Krudsood, Srivicha ^d   Chalermrut, Kobsiri ^d   Silachamroon, Udomsak ^d   Tangpukdee, Noppadon ^d   Allen, James ^a   Brun, Reto ^e   Kwiek, Jesse J ^c   Tidwell, Richard ^c   Looareesuwan, Somchai ^d  

^a Immtech International Inc   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

^e SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 BIS(4 AMIDINOPHENYL)FURAN; AMIDINE; ANTIMALARIAL AGENT; DB 289; DIAMIDINE DERIVATIVE; FURAN DERIVATIVE; PRIMAQUINE; PRODRUG; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AFRICAN TRYPANOSOMIASIS; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENOTYPE; HUMAN; MALARIA; MALE; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; RECURRENCE RISK; THAILAND; TREATMENT OUTCOME;

ANTIPROTOZOAL AGENTS; BENZAMIDINES; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; PILOT PROJECTS; THAILAND;

EID: 22244480296     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/430928     Document Type: Article

References (15)

1. Bell CA, Hall JE, Kyle DE, et al. Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis. Antimicrob Agents Chemother 1990; 34:1381-6.
2. Peters BS, Carlin E, Weston RJ, et al. Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection. Drug Saf 1994; 10:439-54.
3. Yeates C. DB-289 Immtech International. IDrugs 2003; 6:1086-93.
4. Boykin DW, Hall JE, Bender BC, Tidwell RR. Anti-pneumocystis activity of bis-amidoximes and bis-O-alkylamidoxime prodrugs. Biorg Med Chem Lett 1996; 6:3017-20.
5. Yeramian P, Kruze MS, Keczkes S, et al. Clinical pharmacokinetics of DB289, a new orally bioavailable dicationic drug [abstract 1561]. In: Program and abstracts of the 41st Annual International Congress of Antimicrobial Agents and Chemotherapy (Chicago, 2001). Herndon, VA: AMS Press, 2001:255.
6. Singhasivanon P. Mekong malaria: malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia. Southeast Asian J Trop Med Public Health 1999;30(Suppl 4):i-iv, 1-101.
7. Trendler K, Allen J, Hall JE, et al. Quantification of the prodrug DB289 and an active metabolite, DB75, in rat and monkey plasma using SPE, liquid chromatography and electrospray ionization tandem mass spectrometry. AAPS Pharm Sci 2000; 2:abstract 2212.
8. Ngrenngarmlert W, Kwiek JJ, Kamwendo DD, et al. Measuring allelic heterogeneity in Plasmodium falciparum by heteroduplex tracking assay. Am J Trop Med Hyg 2005; 72:694-701.
9. Ismail MA, Brun R, Easterbrook JD, Tanious FA, Wilson WD, Boykin DW. Synthesis and antiprotozoal activity of aza-analogues of furamidine. J Med Chem 2003; 46:4761-9.
10. Bray PG, Barrett MP, Ward SA, de Koning HP. Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol 2003; 19:232-9.
11. Lanteri CA, Trumpower BL, Tidwell RR, Meshnick SR. DB75, a novel trypanocidal agent, disrupts mitochondrial function in Saccharomyces cerevisiae. Antimicrob Agents Chemother 2004; 48:3968-74.
12. Stead AM, Bray PG, Edwards IG, et al. Diamidine compounds: selective uptake and targeting in Plasmodium falciparum. Mol Pharmacol 2001; 59:1298-306.
13. Nguyen B, Hamelberg D, Bailly C, et al. Characterization of a novel DNA minor-groove complex. Biophys J 2004; 86:1028-41.
14. Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ, White NJ. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am J Trop Med Hyg 2004; 71:179-86.
15. Meshnick SR, Taylor TE, Kamchonwongpaisan S. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev 1996; 60:301-15.